Diagnostic gastroenterology

Close Relationships with Companion Animals favoring adoption of Minimally Invasive Procedures to alleviate Post-Surgical Pain charts Growth in Veterinary Endoscopes Market, Market Projected to expand at a CAGR of 7.1% from 2019 - 2027: TMR

Retrieved on: 
Monday, March 15, 2021

Gastrointestinal parasitism infections is a major problem in companion animals and livestock animals that causes oedema, diarrhea, pain, and even death.

Key Points: 
  • Gastrointestinal parasitism infections is a major problem in companion animals and livestock animals that causes oedema, diarrhea, pain, and even death.
  • Besides this, the pain factor of traditional veterinary medicine is resulting in rising acceptance of modern veterinary medicine, including veterinary endoscopy.
  • The increasing aid for veterinary endoscopy provided by governments in some emerging economies is indirectly creating opportunities in the veterinary endoscopes market.
  • Rising acceptance of minimally invasive endoscopic procedures for companion animals, especially for gastrointestinal problems spurring growth in veterinary endoscopes market.

Worldwide Endoscope Reprocessing Devices Industry to 2025 - Increasing Number of Free-Trade Agreements Presents Opportunities

Retrieved on: 
Friday, March 12, 2021

The devices used in the healthcare settings for the reprocessing procedures of the endoscopes are called endoscope reprocessing devices.

Key Points: 
  • The devices used in the healthcare settings for the reprocessing procedures of the endoscopes are called endoscope reprocessing devices.
  • The endoscope reprocessing devices are for deep cleaning of the instruments and devices such as Duodenoscopes, endoscope accessories, and others.
  • There is a growing awareness of advanced endoscope reprocessing in the healthcare sector around the world, with their proven effectiveness for the study of endoscopes.
  • The drive for an automated endoscope reprocessing device stems from the critical need for high-level disinfection for endoscopes of all types.

Aqua Medical Announces First-in-Human Experience of RF Vapor Ablation Therapy for Barrett's Esophagus Published in Endoscopy

Retrieved on: 
Thursday, March 11, 2021

Santa Ana, CA, March 11, 2021 (GLOBE NEWSWIRE) -- Aqua Medical, developer of the FDA 510(k)-cleared vapor-based endoscopic ablation technology for gastrointestinal disease and GI cancer prevention, today announced that clinical results from the first-in-human experience of its RF Vapor Ablation (RFVA) therapy for Barrett's esophagus (BE) were published in Endoscopy.

Key Points: 
  • Santa Ana, CA, March 11, 2021 (GLOBE NEWSWIRE) -- Aqua Medical, developer of the FDA 510(k)-cleared vapor-based endoscopic ablation technology for gastrointestinal disease and GI cancer prevention, today announced that clinical results from the first-in-human experience of its RF Vapor Ablation (RFVA) therapy for Barrett's esophagus (BE) were published in Endoscopy.
  • In the three-phase study, researchers concluded Aqua Medical's RFVA system was successful in safe conversion of targeted BE tissue areas into squamous epithelium.
  • Aqua Medical also announced renowned entrepreneur and venture capitalist William N. (Bill) Starling has joined its Board of Directors.
  • The platform uses high-temperature water vapor created by a radiofrequency generator and delivered endoscopically through proprietary catheters to the GI tract.

Global Endoscope Reprocessing Devices Market (2020 to 2025) - by Product, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 11, 2021

The "Global Endoscope Reprocessing Devices Market (2020-2025) by Product, End User, Geography and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Endoscope Reprocessing Devices Market (2020-2025) by Product, End User, Geography and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Endoscope Reprocessing Market is estimated to be USD 1.95 Bn in 2020 and is expected to reach USD 2.7 Bn in 2025, growing at a CAGR of 7.8%.
  • The devices used in the healthcare settings for the reprocessing procedures of the endoscopes are called endoscope reprocessing devices.
  • The endoscope reprocessing devices are for deep cleaning of the instruments and devices such as Duodenoscopes, endoscope accessories, and others.

Global Endoscopy Market Report 2020 with Focus on 13 Key Players

Retrieved on: 
Thursday, March 4, 2021

DUBLIN, March 4, 2021 /PRNewswire/ -- The "Global Endoscopy Market, 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 4, 2021 /PRNewswire/ -- The "Global Endoscopy Market, 2020" report has been added to ResearchAndMarkets.com's offering.
  • To supply innovative endoscopic technologies, leading market players aim to differentiate themselves with disruptive breakthroughs and distinctive market expansion strategies.
  • These advancements effectively propel the global endoscopy devices market by setting new standards of care delivery and enhanced patient health outcomes.
  • This research indicates that the global endoscopy market, which is currently crowded by traditional rigid and reprocessed endoscopes, will soon experience a major shift toward flexible single-use devices.

Even Before COVID-19, 24% Reported Putting off Their Colonoscopy

Retrieved on: 
Wednesday, March 3, 2021

Colorectal cancer is the third most commonly diagnosed cancer and second leading cause of cancer death in men and women combined in the United States.1

Key Points: 
  • Colorectal cancer is the third most commonly diagnosed cancer and second leading cause of cancer death in men and women combined in the United States.1
    This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210303005537/en/
    Olympus announces key findings from patient surveys on colorectal cancer and other minimally invasive therapies.
  • Nearly a Quarter Avoid or Delay Screening: While the large majority of respondents (82%) understand that colonoscopy is the gold standard for colorectal cancer screening2, nearly 24% of respondents of screening age report purposely avoiding or delaying getting a colonoscopy.
  • Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries.

Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16

Retrieved on: 
Tuesday, March 2, 2021

FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 16, 2021, after the market close.

Key Points: 
  • FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 16, 2021, after the market close.
  • Management will host a conference call and webcast at 4:30 p.m.
  • ET to discuss the results and provide updates on recent corporate developments.

Ambu Named Frost & Sullivan ‘New Product Innovation Award’ Winner for Single-use Flexible Endoscopy

Retrieved on: 
Tuesday, March 2, 2021

Frost & Sullivan selected Ambu due to its work in single-use flexible endoscopy where Ambu is creating an innovation paradigm shift by rapidly bringing new technologies and products in shorter life cycles.

Key Points: 
  • Frost & Sullivan selected Ambu due to its work in single-use flexible endoscopy where Ambu is creating an innovation paradigm shift by rapidly bringing new technologies and products in shorter life cycles.
  • Today, Ambu is the most innovative single-use endoscopy player in the market, with a commitment to be at the forefront of technology, said Pavel Zhebrouski, Best Practices Research Analyst at Frost & Sullivan.
  • Ambu is grateful for this recognition from Frost & Sullivan, whose methodologyfocused on disruptive technology and innovative business modelsis widely respected, said Ambu A/S CEO Juan Jose Gonzalez.
  • Ambu plans to quadruple its product pipeline and launch more than 20 new flexible endoscopy products in the next three years.

Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes

Retrieved on: 
Tuesday, March 2, 2021

The company has announced that it will quadruple its innovation pipeline to launch more than 20 new flexible endoscopy products over the next three years.

Key Points: 
  • The company has announced that it will quadruple its innovation pipeline to launch more than 20 new flexible endoscopy products over the next three years.
  • Its single-use flexible endoscopes are sterile and patient-ready out of the package, eliminating the risk of patient cross-contamination.
  • By combining multiple single-use endoscopes with versatile displays, hospitals can own a cost-efficient, compact, and portable platform.
  • Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies.

Ambu Acclaimed by Frost & Sullivan for Its Groundbreaking Single-use Flexible Endoscopes

Retrieved on: 
Tuesday, March 2, 2021

The company has announced that it will quadruple its innovation pipeline to launch more than 20 new flexible endoscopy products over the next three years.

Key Points: 
  • The company has announced that it will quadruple its innovation pipeline to launch more than 20 new flexible endoscopy products over the next three years.
  • Its single-use flexible endoscopes are sterile and patient-ready out of the package, eliminating the risk of patient cross-contamination.
  • By combining multiple single-use endoscopes with versatile displays, hospitals can own a cost-efficient, compact, and portable platform.
  • Each year, Frost & Sullivan presents this award to the company that develops an innovative element in a product by leveraging leading-edge technologies.